HOLX
Hologic Inc
NASDAQ: HOLX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$76.01
+0.00% today
Updated 2026-04-07
Market cap
$16.97B
P/E ratio
31.54
P/S ratio
4.11x
EPS (TTM)
$2.41
Dividend yield
—
52W range
$52 – $76
Volume
5.0M
Hologic Inc (HOLX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $31.12M | $153.25M | $364.60M | $546.37M | $456.71M | $456.02M | $370.22M | $493.82M | $508.40M | $786.10M | $787.20M | $8.30M | $732.90M | $649.50M | $896.60M | $2.33B | $2.13B | $1.05B | $1.29B | $1.06B |
| Capital expenditures | $40.58M | $22.84M | $53.28M | $65.70M | $52.48M | $64.01M | $83.27M | $90.13M | $80.20M | $89.40M | $98.50M | $107.60M | $105.60M | $113.60M | $156.40M | $162.70M | $127.20M | $150.20M | $140.20M | $137.00M |
| Depreciation | $16.13M | $31.16M | $172.95M | $273.92M | $294.77M | $304.74M | $345.75M | $516.01M | $523.20M | $491.40M | $465.40M | $449.20M | $480.30M | $463.10M | $376.00M | $406.90M | $430.10M | $323.40M | $309.00M | $299.80M |
| Stock-based comp | $3.95M | $6.10M | $1.74M | $32.94M | $34.16M | $35.47M | $40.57M | $52.31M | $50.00M | $59.30M | $65.40M | $68.20M | $65.00M | $62.00M | $83.30M | $65.00M | $66.70M | $79.60M | $82.30M | $84.30M |
| Free cash flow | $-9.46M | $130.41M | $311.31M | $480.66M | $404.23M | $392.02M | $286.95M | $403.69M | $428.20M | $696.70M | $688.70M | $-99.30M | $627.30M | $535.90M | $740.20M | $2.17B | $2.00B | $901.00M | $1.15B | $920.10M |
| Investing cash flow | $-206.68M | $-59.23M | $-2.68B | $-61.52M | $-66.98M | $-266.59M | $-3.85B | $18.75M | $-67.00M | $-86.10M | $-68.40M | $285.80M | $-195.20M | $-280.70M | $-141.60M | $-1.33B | $-206.30M | $-152.10M | $-781.00M | $-482.70M |
| Financing cash flow | $90.60M | $-22.46M | $2.31B | $-288.62M | $-167.57M | $7.67M | $3.33B | $-248.77M | $-525.10M | $-936.70M | $-659.70M | $-309.20M | $-404.80M | $-431.50M | $-659.90M | $-529.80M | $-756.00M | $-483.20M | $-1.11B | $-777.20M |
| Dividends paid | — | — | — | $0.00 | $2.68M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $250.00M | $393.00M | $33.20M | $49.80M | $65.60M | $51.30M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $197.53M | $222.44M | $196.71M | $-151.90M | $262.06M | $-86.40M | $-244.80M | $57.10M | $-7.80M | $126.10M | — | $95.10M | $471.00M | $1.16B | — | — | — |